English
Shaping together the future
of medical imaging
Thanks to the continued support of its investors,
Intrasense has expanded its portfolio and
business activities to address new markets
in France and worldwide.
We are ambitious. We are passionate.
We believe in the future through innovation.
News & strategies
Let us share
our strategic directions.
We have identified major opportunities opening up for new applications of Myrian® innovative technologies in the fields of health information systems, artificial intelligence and deep-learning.
Let’s share our road map >
Read our latest news >
Receive "live" our news >
Financial documentation
Let's read
our latest publications.
Press release Intrasense Group consolidated 2020 annual results >
Press release general meeting postponement >
Answers to RegroupementPPlocal 1-20 >
Answers to RegroupementPPlocal 21-40 >
Letter to shareholders >
Accounts & reports >
Regulated information >
General meetings >
OCABSA-OCA >
If you cannot find the information you are looking for, please do not hesitate to contact us.
Agenda
> 21/03/23 - Yearly results publication
> 20/06/24 - GENERAL MEETING (FRENCH)
> 20/06/03 - Shareholder webinar
> 20/05/20 - Letter to shareholders
> 20/05/18 - Publication of the meeting notice
Stock market data
Identification
Name: Intrasense
Ticker symbol : ALINS
ISIN code : FR0011179886
Bloomberg : ALINS:FP
Reuters : ALINS.PA
Number of shares : 23.378.925
Capital distribution
